Literature DB >> 33316762

Must-access prescription drug monitoring programs and the opioid overdose epidemic: The unintended consequences.

Bokyung Kim1.   

Abstract

Although supply-side drug policies that limit access to legal opioids have reduced prescription opioid abuse, growing evidence shows that these policies have had the unintended consequence of increasing use of illegal opioids, including heroin. I add to this literature by studying the consequences of must-access prescription drug monitoring programs (PDMPs), which legally require providers to access a state-level database with a patient's prescription history before prescribing controlled substances under certain circumstances. Using a difference-in-differences specification, I find strong evidence that must-access PDMPs have increased heroin death rates. My estimates indicate that two years after implementation, must-access PDMPs were associated with 0.9 more heroin deaths per 100,000 in a half-year period, relative to control states. My results suggest that even if must-access PDMPs reduce prescription opioid deaths, the decrease is offset by a large increase in illegal opioid deaths.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Heroin; Must-access PDMP; Opioid; Opioid epidemic; Opioid overdose; Prescription drug monitoring program

Year:  2020        PMID: 33316762     DOI: 10.1016/j.jhealeco.2020.102408

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  4 in total

1.  Medically treated opioid overdoses among New Jersey Medicaid beneficiaries: Rapid growth and complex comorbidity amid growing fentanyl penetration.

Authors:  Stephen Crystal; Molly Nowels; Mark Olfson; Hillary Samples; Arthur Robinson Williams; Peter Treitler
Journal:  J Subst Abuse Treat       Date:  2021-06-24

2.  Can electronic prescribing mandates reduce opioid-related overdoses?

Authors:  Rahi Abouk; David Powell
Journal:  Econ Hum Biol       Date:  2021-04-09       Impact factor: 2.774

3.  Substitution of Nonpharmacologic Therapy With Opioid Prescribing for Pain During the COVID-19 Pandemic.

Authors:  Byungkyu Lee; Kai-Cheng Yang; Patrick Kaminski; Siyun Peng; Meltem Odabas; Sumedha Gupta; Harold D Green; Yong-Yeol Ahn; Brea L Perry
Journal:  JAMA Netw Open       Date:  2021-12-01

4.  "The DEA would come in and destroy you": a qualitative study of fear and unintended consequences among opioid prescribers in WV.

Authors:  Cara L Sedney; Treah Haggerty; Patricia Dekeseredy; Divine Nwafor; Martina Angela Caretta; Henry H Brownstein; Robin A Pollini
Journal:  Subst Abuse Treat Prev Policy       Date:  2022-03-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.